The influence of the mycotoxin deoxynivalenol on jejunal glucose transport in pigs.

Mycotoxin Res

Institute of Animal Nutrition, Federal Agricultural Research Centre (FAL), Bundesallee 50, 38116, Braunschweig, Germany.

Published: December 2005

The experiments were aimed at evaluating whether the activity of the glucose transporter in the pig's jejunum is affected by deoxynivalenol (DON)-contaminated feed. This is based on the ability of DON to inhibit the protein synthesis on cellular level which might also involve the synthesis of the intestinal glucose transporter.Two groups of six castrated male pigs were restrictively fed a control or a DON contaminated diet (=5.7 mg/kg). Immediately after slaughtering the pigs, the mid-jejunum was quickly dissected, washed, frozen and stored at -80°C until preparations. Brush border membrane vesicles (BBMV) were prepared by Mg(2+)-EGTA-precipitation and differential centrifugation. The activity of the glucose transporter was examined by measuring the uptake of [(3)H]-glucose into the BBMV. The glucose uptake was quantified by using the rapid filtration technique.The glucose uptake into BBMV followed Michaelis-Menten-kinetic. Comparison of the kinetic parameters Vmax (transport capacity) and Km (transport affinity) of the two treatment-groups showed no significant differences between feeding a DON-contaminated or control diet. It was concluded that dietary DON exposure (=5.7 mg/kg) for five weeks had no obvious influence on the intestinal glucose transporter and its activity in pigs.

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF02957587DOI Listing

Publication Analysis

Top Keywords

glucose transporter
12
activity glucose
8
intestinal glucose
8
=57 mg/kg
8
glucose uptake
8
glucose
7
influence mycotoxin
4
mycotoxin deoxynivalenol
4
deoxynivalenol jejunal
4
jejunal glucose
4

Similar Publications

Quercetin (QE), a particular flavonoid, is well known for its medicinal effects, including anti-oxidant, hypoglycemic, and anti-inflammatory effects. In this review, the findings of QE effects on diabetes STZinduced, alloxan-induced, and its complications have been summarized with a particular focus on in vitro, in vivo, and clinical trials. Consequently, QE mediates several mechanisms, including ameliorating tumor necrosis factor (TNF)-α, nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), interleukin (IL)-1β, IL-8, and IL-10 expression, increasing insulin glucose uptake to inhibit insulin resistance.

View Article and Find Full Text PDF

Type 3 deiodinase activation mediated by the Shh/Gli1 axis promotes sepsis-induced metabolic dysregulation in skeletal muscles.

Burns Trauma

January 2025

Department of Critical Care Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, No. 321 Zhongshan Road, Gulou District, Nanjing, Jiangsu 210008, China.

Background: Non-thyroidal illness syndrome is commonly observed in critically ill patients, characterized by the inactivation of systemic thyroid hormones (TH), which aggravates metabolic dysfunction. Recent evidence indicates that enhanced TH inactivation is mediated by the reactivation of type 3 deiodinase (Dio3) at the tissue level, culminating in a perturbed local metabolic equilibrium. This study assessed whether targeted inhibition of Dio3 can maintain tissue metabolic homeostasis under septic conditions and explored the mechanism behind Dio3 reactivation.

View Article and Find Full Text PDF
Article Synopsis
  • Colorectal cancer (CRC) is a major cause of cancer deaths, and oxaliplatin (OXA) is a primary treatment that faces challenges due to the tumor microenvironment (TME).
  • A new multifunctional nanosystem, Rg3-Lip-OXA/CaO, uses Ginsenoside Rg3 liposomes to target CRC cells, delivering OXA and calcium peroxide (CaO) together.
  • Research showed that this nanosystem had good stability and release properties, effectively targeted cancer cells, and significantly suppressed tumor growth in mice, while also showing manageable acute toxicity.
View Article and Find Full Text PDF

Systemic lupus erythematosus and pulmonary tuberculosis in a patient developing acute-onset type 1 diabetes.

Diabetol Int

January 2025

Department of Endocrinology and Diabetes, NTT Medical Center Tokyo, 141-86255-9-22 Higashi-Gotanda, Shinagawa-ku, Tokyo Japan.

A 73-year-old Japanese woman was admitted to our hospital with anorexia, weight loss, and fever. A few weeks prior to admission, she became aware of anorexia. She was leukopenic, complement-depleted, and positive for antinuclear antibodies and anti-double stranded DNA antibodies.

View Article and Find Full Text PDF

We report a beneficial effect of a sodium glucose co-transporter 2 (SGLT2) inhibitor in the management of insulin resistant diabetes mellitus (IRDM) in a Japanese girl with mild Rabson-Mendenhall syndrome (RMS). At 10 2/12 years of age, she was referred to us because of glucosuria, and was found to have marked acanthosis nigricans and RMS-like facial features such as proptosis, large ears, full lips, and gingival hypertrophy, but not other clinical features frequently found in RMS. At 11 9/12 years of age, her blood HbA1c level, though it remained ~ 6.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!